🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of a Mobile Application-Based Medication Reminder on Treatment Adherence Among Patients With Chronic Diseases and Memory Impairment: A Nursing Leadership Perspective

RecruitingNAAges 18 Years - anyAllMansoura University
NCT07718334 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to evaluate the impact of using a mobile application-based medication reminder on medication adherence among patients diagnosed with chronic diseases and memory impairment. Adherence to prescribed therapy is a significant challenge for this patient population, often leading to poor health outcomes and increased healthcare costs. From a nursing leadership perspective, innovative digital solutions can play a crucial role in supporting patient self-management. Using a quasi-experimental design, the study will investigate whether a customized mobile reminder system can effectively improve adherence rates and support patients in managing their therapeutic regimens.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients diagnosed with one or more chronic diseases requiring regular long-term medication. * Patients exhibiting mild-to-moderate memory impairment or cognitive decline as screened by the Mini-Mental State Examination (MMSE). * Patients who personally own and are capable of operating a smartphone or have a primary caregiver willing to manage the mobile application. * Patients aged 18 years and older. * Patients who provide voluntary informed consent to participate in the study. Exclusion Criteria: * Patients with severe cognitive impairment or advanced dementia who cannot interact with mobile technology even with caregiver assistance. * Patients with severe acute clinical complications or unstable psychiatric conditions. * Patients participating in another concurrent clinical trial or study targeting medication adherence
💊

What it tests

  • Mobile Application-Based Medication Reminder
📍

Where

2 sites
Outpatient Clinics, Delta University for Science and Technology
Gamasa, Egypt
Outpatient Clinics, Kafr El-Sheikh Hospital
Kafr ash Shaykh, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy